Basecamp Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.15M Sell
4,353
-1,450
-25% -$383K 0.26% 34
2026
Q2
$1.47M Sell
5,803
-155
-3% -$36.1K 0.27% 39
2026
Q1
$1.46M Buy
5,958
+149
+3% +$34.7K 0.3% 33
2025
Q4
$1.2M Buy
+5,809
New +$1.15M 0.26% 41

Other funds holding JNJ

Basecamp Wealth Advisors's JNJ Position: Q3 2026 in Review

Basecamp Wealth Advisors reduced its Johnson & Johnson (JNJ) stake by 25% in Q3 2026, selling an estimated $383K and leaving 4,353 shares worth $1.15M. The position accounts for 0.26% of the portfolio, ranked #34.

Basecamp Wealth Advisors first reported a position in JNJ in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.47M in Q2 2026. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Basecamp Wealth Advisors held 4,353 shares of Johnson & Johnson worth $1.15M as of Q3 2026.
  • Basecamp Wealth Advisors sold 1,450 Johnson & Johnson shares in Q3 2026, an estimated $383K.
  • Johnson & Johnson made up 0.26% of Basecamp Wealth Advisors's portfolio in Q3 2026, its #34 holding.
  • Basecamp Wealth Advisors first reported a position in Johnson & Johnson in Q4 2025 and has held it in 4 quarters since.
  • Basecamp Wealth Advisors's Johnson & Johnson position peaked at $1.47M in Q2 2026.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.